news Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance By AdminMay 6, 2026Less 1 min read43 Views0 Novo Nordisk raised its outlook for 2026 after a strong performance from its newly launched Wegovy pill. ShareTweetPinShare Previous Post5 Takeaways From the California Gubernatorial Debate Next PostCNBC’s UK Exchange newsletter: It’s not the 1970s, but the oil shock is still biting hard Leave a Reply Your email address will not be published. Required fields are marked * Save my name, email, and website in this browser for the next time I comment. You May Also Like April 20, 20260 Comments Oklahoma principal crowned prom king for his heroism April 28, 20260 Comments BP profits more than double, beating expectations as Iran war boosts oil prices January 9, 20260 Comments Hopes rise for Chinese property support ahead of key March meeting May 5, 20260 Comments Bulls are piling into this Warren Buffett favorite ahead of earnings
April 28, 20260 Comments BP profits more than double, beating expectations as Iran war boosts oil prices